Lantus (TYA Pharmaceuticals)


Welcome to the PulseAid listing for the Lantus drug offered from TYA Pharmaceuticals. This Insulin [Chemical/Ingredient],Insulin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: TYA Pharmaceuticals
NON-PROPRIETARY NAME: insulin glargine
SUBSTANCE NAME: INSULIN GLARGINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Insulin [Chemical/Ingredient],Insulin Analog [EPC]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-09-23
END MARKETING DATE: 0000-00-00


Lantus HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLantus from TYA Pharmaceuticals
LABELER NAME: TYA Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 100([iU]/mL)
START MARKETING DATE: 2009-09-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64725-2220_7d9b3b09-2b30-40a4-8b37-38d2e6af3abf
PRODUCT NDC: 64725-2220
APPLICATION NUMBER: NDA021081

Other INSULIN GLARGINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Dispensing Solutions, Inc.Lantus
Eli Lilly and CompanyBASAGLAR
Physicians Total Care, Inc.Lantus
sanofi-aventis U.S. LLCLantus Solostar
Sanofi-Aventis U.S. LLCTOUJEO
TYA PharmaceuticalsLantus